SlideShare a Scribd company logo
1 of 48
Benign Diseases of
Thyroid and
Hyperthyroidism PRAVEEN R K
NO: 75
HYPOTHYROIDISM
CRETINISM
▶ Inadequate thyroid hormone during foetal and neonatal
development
▶ Two types
▶ Endemic - Due to dietary iodine deficiency
▶ Sporadic - Due to either an inborn error of thyroid
metabolism or complete or partial agenesis of the
gland.
CLINICAL FEATURES
▶ Hoarse cry
▶ Macroglossia
▶ Growth retardation
▶ Mental retardation
▶ Umbilical hernia
▶ Immediate diagnosis and treatment with thyroxine within a few
days of birth are essential to prevent in utero damage progressing.
ADULT HYPOTHYROIDISM
▶ Mild Thyroid deficiency is common
▶ Severe thyroid failure results in Myxoedema
SYMPTOMS
▶ Tiredness
▶ Mental lethargy
▶ Cold intolerance
▶ Weight gain
▶ Constipation
▶ Menstrual disturbance
▶ Carpal tunnel syndrome
SIGNS
▶ Bradycardia
▶ Cold extremities
▶ Dry skin and hair
▶ Periorbital puffiness
▶ Hoarse voice
▶ Bradykinesia, slow movements
▶ Delayed relaxation phase of ankle jerk
LAB FINDINGS
▶ Thyroid function tests
▶ Low T4 and T3 levels with a high TSH
▶ High serum levels of TPO antibodies are characteristic of
autoimmune disease.
TREATMENT
▶ Oral thyroxine (0.1 – 0.2 mg) as a single daily dose is curative.
▶ Triiodothyronine(20 μg three times a day) , if rapid response is
required
MYXOEDEMA
▶ Adult onset severe hypothyroidism
▶ The signs and symptoms of hypothyroidism
are accentuated
▶ Facial appearance is typical
 Supra clavicular puffiness
 Malar flush
 A yellow tinge to the skin
▶ Myxoedema coma -
 Altered mental state
 Hypothermia
 Precipitating medical condition - cardiac failure or infection
 High mortality rate
TREATMENT
▶ Thyroid replacement, either as a bolus of 0.5 mg of T4 or 10 μg of
T3 either i.v / orally every 4–6 hrs
▶ Body Temp <30oC - warmed slowly
▶ IV broad spectrum antibiotics and Hydrocotisone (divided doses)
DYSHORMONOGENESIS
Genetic deficiencies in the enzymes controlling the synthesis of
thyroid hormones
▶ Inherited as autosomal recessive
▶ Family history is common
▶ If biochemical effect is of moderate degree, Thyroid enlargement
may be the only manifestation
▶ Most common abnormalities affect TPO activity and thyroglobulin
synthesis.
▶ Eg: Pendred’s syndrome – goitre + severe sensorineural hearing loss
+ abnormality of bony labyrinth
GOITRE
THYROID ENLARGEMENT
▶ Normal thyroid gland is impalpable
▶ ‘Goitre’ – generalised enlargement of thyroid gland
SIMPLE GOITRE
▶ Aetiopathogenesis -
▶ Stimulation due to increased TSH  Decreased level of
circulating thyroid hormones or due to inappropriate secretion
from a microadenoma in ant. Pituitary.
▶ MC factor is dietary deficiency of iodine (endemic goitre)
▶ Following are causes of such goitre:
▶ Endemic goitre -iodine deficiency
▶ Dyshormonogenesis or Enzyme deficiency
▶ Goitrogens – vegetables of brassica (cabbage)
Stages of goitre formation
▶ Initially Persistent growth stimulation – diffuse hyperplasia
▶ Later Fluctuating stimulation – mixed pattern with areas of active
lobules and inactive lobules
▶ Active lobules – become more vascular & hyperplastic –
hemorrhage occurs– central necrosis
▶ Necrotic lobules coalesce – nodules filled with iodine free colloid or
mass of new but inactive follicles
▶ Continual repetition of process – results in nodular goitre
DIFFUSE HYPERPLASTIC GOITRE
▶ Corresponds to first stage of natural history
▶ Goitre in childhood usually seen in endemic areas,
sporadic cases usually occurs in puberty
▶ Goitre is soft, diffuse, large enough to cause
discomfort
▶ Colloid goitre occurs in late stage when TSH
stimulation has fallen off
MULTINODULAR GOITRE
▶ C/P - Females-late 30s or 40s-multiple
palpable nodules
▶ Occasionally a solitary nodule may be
palpable but there are multiple small
nodules impalpable.
▶ Nodules may be colloid or cellular, cystic
degeneration and hemorrhage.
COMPLICATIONS
▶ Secondary thyrotoxicosis – in about 30% nodular goitre.
▶ Tracheal obstruction – huge goitres or substernal prolongation of
goitre
▶ Carcinoma (usually follicular)
Investigations
▶ Thyroid Function Tests
▶ Isotope scan-to differentiate hot and cold nodules.
▶ USG
▶ FNAC
▶ Core biopsy
▶ CT and MRI
▶ Thyroid autoantibodies
▶ Chest radiography
TREATMENT
▶ Most patients are asymptomatic and do not need operation
▶ Operation may be indicated on cosmetic grounds, for pressure
symptoms, or in response to patient anxiety
▶ Choice of surgery
▶ Total thyroidectomy
▶ Subtotal thyroidectomy
▶ Total lobectomy
SOLITARY NODULE THYROID
▶ Isolated thyroid swelling
▶ Isolated , confined to one or other lateral lobe or to
isthmus.
▶ Mostly they are SNG formed by inactive colloid or
apparently localized manifestations of simple MNG.
▶ Also include-#neoplastic - benign/malignant
#cysts
#localised chronic lymphocytic
thyroiditis.
THYROID CYSTS
▶ Routine FNAC shows that >30% of clinically isolated swellings
contain fluid-are cystic or partially cystic.
▶ Tense cysts – hard &mimic carcinoma
▶ Bleeding into cysts- acute painful swelling.
▶ 50% as a result of colloid degeneration or of uncertain etiology like
absence of epithelial cells in the lining.
▶ C/P- In women aged 20-40 yrs - as discrete swellings
▶ Appropriate investigation : FNAC
RETROSTERNAL GOITRE
▶ Arise from lower pole of nodular goitre, from ectopic thyroid tissue.
▶ If neck is short and pretracheal muscles are strong , -ve intrathoracic
pressure tends to draw the goitre into the superior mediastinum.
▶ Obstructive symptoms - dyspnea, cough and stridor, dysphagia,
engorgement of neck veins, recurrent nerve paralysis
▶ Xray- soft tissue shadow in superior mediastinum, deviation and
compression of trachea
THYROIDITIS
CHRONIC LYMPHOCYTIC THYROIDITIS
▶ Autoimmune disease - HASHIMOTO’S DISEASE
▶ Raised titres of thyroid antibodies.
▶ C/P : diffuse or nodular with a characteristic bosselated feel or
subclinical thyroid failure.
▶ Onset may be insidious and asymptomatic or sudden and painful.
▶ Initially mild hyperthyroidism later hypothyroidism
▶ Goitre is usually lobulated ; diffuse or localised to one lobe.
▶ Large or small ; soft , rubbery or firm in consistency- depending on
cellularity and degree of fibrosis.
▶ Mc –women at menopause
▶ DIAGNOSIS- Raised serum levels of one or more thyroid antibodies,
FNAC, diagnostic lobectomy
SUBACUTE THYROIDITIS
▶ Granulomatous thyroiditis ; de Quervain’s thyroiditis.
▶ May follow viral infection
▶ C/F: pain in neck , fever , malaise and firm, irregular enlargement of
one or both thyroid lobes
▶ Raised inflammatory markers , absent thyroid antibodies , serum T4
is slightly raised
▶ Self limiting - a period of months of hypothyroidism may be present
before eventual recovery
▶ DIAGNOSIS - FNAC , radioactive iodine uptake and by rapid
symptomatic response to prednisolone.
▶ TREATMENT- PREDNISOLONE 10-20mg daily for 1 week & then
gradually reduced dose over next month
REIDEL’S THYROIDITIS
▶ Very rare - 0.5% of goitres.
▶ Thyroid tissue replaced by cellular fibrous tissue - infiltrates through
capsule into muscle and adjacent structures including parathyroid,
recurrent nerves, carotid sheath.
▶ Probably a collagen disease
▶ Goitre may be U/L or B/L - very hard and fixed
▶ TREATMENT-High dose steroid, tamoxifen, thyroxine replacement
HYPERTHYROIDISM
HYPERTHYROIDISM
▶ Hyperthyroidism –term used for over production of thyroid
hormones
▶ Pathology is in thyroid gland itself
▶ Hyperthyroidism is one of the causes of thyrotoxicosis
▶ Thyrotoxicosis is symptom complex due to increased levels of
thyroid hormones
▶ It refers to biochemical and physiological manifestations of
excessive thyroid hormones
CLINICAL CLASSIFICATION
▶ Diffuse toxic goitre (Graves’ disease, Primary thyrotoxicosis)
▶ Toxic nodular goitre (Secondary thyrotoxicosis)
▶ Toxic nodule
▶ Hyperthyroidism due to rarer causes
Diffuse toxic goitre (Grave’s Disease)
▶ A Diffuse vascular goitre appearing at the same time as the
hyperthyroidism, usually occurs in younger women and is frequently
associated with eye signs.
▶ The syndrome is that of primary thyrotoxicosis
▶ 50 % family history of autoimmune endocrine diseases.
▶ Thyroid stimulating immunoglobulins and long acting thyroid
stimulator are responsible for pathological changes.
▶ Whole functioning thyroid tissue is involved
▶ Hypertrophy and hyperplasia due to abnormal thyroid stimulating
antibodies (TSH-RAb) that bind to TSH receptor sites and produce a
disproportionate and prolonged effect
TOXIC NODULAR GOITRE
▶ Simple nodular goitre is present for a long time before the
hyperthyroidism, usually in the middle-aged or elderly, and very
infrequently associated with eye signs
▶ The syndrome is that of secondary thyrotoxicosis.
▶ In many cases- nodules are inactive
▶ Inter nodular thyroid tissue – over active
▶ However, in some toxic nodular goitres, one or more nodules are
overactive and here the hyperthyroidism is due to autonomous
thyroid tissue as in a toxic adenoma
TOXIC NODULE
▶ A solitary overactive nodule
▶ It may be part of a generalised nodularity or a true toxic adenoma.
▶ It is autonomous and its hypertrophy and hyperplasia are not due
to TSH-R Ab.
▶ TSH secretion is suppressed by the high level of circulating thyroid
hormones and the normal thyroid tissue surrounding the nodule is
itself suppressed and inactive.
Symptomatology
▶ 8 times more common in women
▶ Significant symptoms- loss of weight despite good appetite, recent
preference for cold, and palpitations
▶ Significant signs- excitability of patient, presence of goitre, exophthalmos,
tachycardia or cardiac arrhythmia
▶ Primary thyrotoxicosis- goitre is diffuse and vascular, large or small, firm or
soft, onset is abrupt, a thrill and a bruit may be present,
▶ Secondary thyrotoxicosis- goitre is nodular, onset is insidious, may present
with cardiac failure or atrial fibrillation
CLINICAL FEATURE
Symptoms
▶ Tiredness
▶ Emotional liability
▶ Heat intolerance
▶ Weight loss
▶ Excessive appetite
▶ Palpitations
▶ Proximal myopathy
EYE SIGNS
LID RETRACTION
▶ Over activity of involuntary part of the levator palpebrae superioris
muscle.
▶ The upper eye lid is higher than normal and the lower eyelid is in its
normal position
Exophthalmos
▶ When eyeball is pushed forwards due to increase in fat or oedema
or cellular infiltration in the retro orbital space the eyelids are
retracted and sclera becomes visible below the lower edge of the
iris first followed by above the upper edge of the iris
▶ Von Graefe's sign.— The upper eyelid lags behind the eyeball as the
patient is asked to look downwards.
▶ Stellwag's sign — This is staring look and infrequent blinking of eyes with
widening of palpebral fissure
▶ Joffroy’s sign – absence of wrinkling on forehead when patient looks up
with head bent down.
▶ Moebius' sign — Inability or failure to converge the eyeballs.
▶ Dalrymple's sign— The upper sclera is visible due to retraction of upper
eye lid
▶ Ophthalmoplegia
▶ Chemosis, papilloedema, corneal ulcer
▶ Cardiac manifestations
▶ Multiple extrasystoles, paroxysmal atrial tachycardia, paroxysmal
atrial fibrillation, persistent atrial fibrillation
▶ Myopathy
▶ Proximal muscle weakness
▶ Pretibial myxoedema
▶ Bilateral, symmetrical, shiny red, thickened dry skin with coarse
hair in feet and ankles
▶ Usually in areas of trauma , by deposition of hyaluronic acid in
dermis and subcutis
INVESTIGATIONS
▶ Thyroid function tests
Type of disease T 4 T3 TSH
Hyperthyroidism Increased Increased Undetectable
▶ Radioisotope study – I123 more uptake – hot nodules
▶ TRH estimation
▶ ECG- cardiac involvement
▶ Total count and neutrophil count
▶ Thyroid antibody estimation
TREATMENT
▶ Relief of symptoms
▶ Beta blocker- control cardiovascular manifestation
▶ Calcium channel blocker
▶ Oral rehydration
▶ Antithyroid drugs
▶ Methimazole 20 – 40 mg OD (blocks thyroid hormone synthesis)
▶ Carbimazole 5-10 mg three times a day
▶ Propyl thiouracil 200 mg three times a day (blocks thyroid
hormone synthesis as well as blocks peripheral conversion of T4
to T3)
▶ Iodides – reduce vascularity
▶ Steroids
▶ Radioactive iodine therapy – I131
▶ Destroys cells and cause complete ablation of thyroid gland
▶ Usual dose- 5 to 10 millicurie or 160 microcurie/gm of thyroid
▶ Surgery
▶ Total thyroidectomy
▶ Subtotal thyroidectomy
▶ Hemithyroidectomy
”
“ THANK YOU

More Related Content

Similar to benigndiseasesofthyroid-75-180721101151.pptx

goiter 2-170 323180 82 2 (1).pdf
goiter         2-170 323180 82 2 (1).pdfgoiter         2-170 323180 82 2 (1).pdf
goiter 2-170 323180 82 2 (1).pdf
deborayilma
 
Anaesthetic mgt for pt with hyperthyroidism pritam
Anaesthetic mgt for pt with hyperthyroidism  pritamAnaesthetic mgt for pt with hyperthyroidism  pritam
Anaesthetic mgt for pt with hyperthyroidism pritam
havalprit
 
Surg path thyroid.special
Surg path thyroid.specialSurg path thyroid.special
Surg path thyroid.special
specialclass
 

Similar to benigndiseasesofthyroid-75-180721101151.pptx (20)

Disorders of the thyroid gland
Disorders of the thyroid glandDisorders of the thyroid gland
Disorders of the thyroid gland
 
Thyroid parathyroid kinara
Thyroid parathyroid kinaraThyroid parathyroid kinara
Thyroid parathyroid kinara
 
Thyroid Gland - Overview
Thyroid Gland - OverviewThyroid Gland - Overview
Thyroid Gland - Overview
 
goitre
goitregoitre
goitre
 
Hyperthyroidism Ppt.pptx
Hyperthyroidism Ppt.pptxHyperthyroidism Ppt.pptx
Hyperthyroidism Ppt.pptx
 
Approach to endocrine disorders
Approach to endocrine disordersApproach to endocrine disorders
Approach to endocrine disorders
 
pitutary Disorder.pptx
pitutary Disorder.pptxpitutary Disorder.pptx
pitutary Disorder.pptx
 
Benign thyroid diseases
Benign thyroid diseasesBenign thyroid diseases
Benign thyroid diseases
 
Hypothyroidism.pptx
Hypothyroidism.pptxHypothyroidism.pptx
Hypothyroidism.pptx
 
hyperthrodism-WPS Office copy.pptx
hyperthrodism-WPS Office copy.pptxhyperthrodism-WPS Office copy.pptx
hyperthrodism-WPS Office copy.pptx
 
Thyroid
ThyroidThyroid
Thyroid
 
Hyperthyroidism-2022.pptx
Hyperthyroidism-2022.pptxHyperthyroidism-2022.pptx
Hyperthyroidism-2022.pptx
 
Thyrotoxicosis, hyperthyroidism
Thyrotoxicosis, hyperthyroidismThyrotoxicosis, hyperthyroidism
Thyrotoxicosis, hyperthyroidism
 
Thyroid Gland . Iman Alhussein
Thyroid Gland . Iman AlhusseinThyroid Gland . Iman Alhussein
Thyroid Gland . Iman Alhussein
 
THYROID_GLAND[1].pptx
THYROID_GLAND[1].pptxTHYROID_GLAND[1].pptx
THYROID_GLAND[1].pptx
 
goiter 2-170 323180 82 2 (1).pdf
goiter         2-170 323180 82 2 (1).pdfgoiter         2-170 323180 82 2 (1).pdf
goiter 2-170 323180 82 2 (1).pdf
 
Goiter
GoiterGoiter
Goiter
 
Anaesthetic mgt for pt with hyperthyroidism pritam
Anaesthetic mgt for pt with hyperthyroidism  pritamAnaesthetic mgt for pt with hyperthyroidism  pritam
Anaesthetic mgt for pt with hyperthyroidism pritam
 
Goitre treatment and management accordingly
Goitre treatment and management accordinglyGoitre treatment and management accordingly
Goitre treatment and management accordingly
 
Surg path thyroid.special
Surg path thyroid.specialSurg path thyroid.special
Surg path thyroid.special
 

Recently uploaded

Catheterization Procedure by Anushri Srivastav.pptx
Catheterization Procedure by Anushri Srivastav.pptxCatheterization Procedure by Anushri Srivastav.pptx
Catheterization Procedure by Anushri Srivastav.pptx
AnushriSrivastav
 
تقرير منظمة الصحة العالمية الخاص بالغذاء د حاتم البيطار.pdf
تقرير منظمة الصحة العالمية الخاص بالغذاء د حاتم البيطار.pdfتقرير منظمة الصحة العالمية الخاص بالغذاء د حاتم البيطار.pdf
تقرير منظمة الصحة العالمية الخاص بالغذاء د حاتم البيطار.pdf
د حاتم البيطار
 
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
DanielOliver74
 

Recently uploaded (20)

Catheterization Procedure by Anushri Srivastav.pptx
Catheterization Procedure by Anushri Srivastav.pptxCatheterization Procedure by Anushri Srivastav.pptx
Catheterization Procedure by Anushri Srivastav.pptx
 
Pharmacology and Toxicology Thesis Defense by Slidesgo.pptx
Pharmacology and Toxicology Thesis Defense by Slidesgo.pptxPharmacology and Toxicology Thesis Defense by Slidesgo.pptx
Pharmacology and Toxicology Thesis Defense by Slidesgo.pptx
 
Clinical pharmacy book by parthasarathi.pdf
Clinical pharmacy book by  parthasarathi.pdfClinical pharmacy book by  parthasarathi.pdf
Clinical pharmacy book by parthasarathi.pdf
 
Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...
Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...
Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...
 
تقرير منظمة الصحة العالمية الخاص بالغذاء د حاتم البيطار.pdf
تقرير منظمة الصحة العالمية الخاص بالغذاء د حاتم البيطار.pdfتقرير منظمة الصحة العالمية الخاص بالغذاء د حاتم البيطار.pdf
تقرير منظمة الصحة العالمية الخاص بالغذاء د حاتم البيطار.pdf
 
MOTOR NEURON DISEASE - Presentation Neuro
MOTOR NEURON DISEASE - Presentation NeuroMOTOR NEURON DISEASE - Presentation Neuro
MOTOR NEURON DISEASE - Presentation Neuro
 
Digital Healthcare: The Future of Medical Consultations
Digital Healthcare: The Future of Medical ConsultationsDigital Healthcare: The Future of Medical Consultations
Digital Healthcare: The Future of Medical Consultations
 
The Pfizer testimony by Melissa Mac Atee
The Pfizer testimony by Melissa Mac AteeThe Pfizer testimony by Melissa Mac Atee
The Pfizer testimony by Melissa Mac Atee
 
Storage_of _Bariquin_Components_in_Storage_Boxes.pptx
Storage_of _Bariquin_Components_in_Storage_Boxes.pptxStorage_of _Bariquin_Components_in_Storage_Boxes.pptx
Storage_of _Bariquin_Components_in_Storage_Boxes.pptx
 
Antiepileptic-Drugs-and-Congenital-Anomalies copy.pptx
Antiepileptic-Drugs-and-Congenital-Anomalies copy.pptxAntiepileptic-Drugs-and-Congenital-Anomalies copy.pptx
Antiepileptic-Drugs-and-Congenital-Anomalies copy.pptx
 
Ovarian Hyperstimulation Syndrome Case Presentation.pptx
Ovarian Hyperstimulation Syndrome Case Presentation.pptxOvarian Hyperstimulation Syndrome Case Presentation.pptx
Ovarian Hyperstimulation Syndrome Case Presentation.pptx
 
Best Way 30-Days Keto Meal Plan For Diet
Best Way 30-Days Keto Meal Plan For DietBest Way 30-Days Keto Meal Plan For Diet
Best Way 30-Days Keto Meal Plan For Diet
 
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
 
2024 03 Monumental Mistakes in EMS BAD EMS v0.2.pdf
2024 03 Monumental Mistakes in EMS BAD EMS v0.2.pdf2024 03 Monumental Mistakes in EMS BAD EMS v0.2.pdf
2024 03 Monumental Mistakes in EMS BAD EMS v0.2.pdf
 
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, India
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, IndiaDr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, India
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, India
 
LTM Session-8-Practices-that-assist-BF..ppt
LTM Session-8-Practices-that-assist-BF..pptLTM Session-8-Practices-that-assist-BF..ppt
LTM Session-8-Practices-that-assist-BF..ppt
 
Importance of Diet on Dental Health.docx
Importance of Diet on Dental Health.docxImportance of Diet on Dental Health.docx
Importance of Diet on Dental Health.docx
 
Mental Health Startup Pitch Deck Presentation
Mental Health Startup Pitch Deck PresentationMental Health Startup Pitch Deck Presentation
Mental Health Startup Pitch Deck Presentation
 
PhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptxPhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptx
 
Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...
Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...
Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...
 

benigndiseasesofthyroid-75-180721101151.pptx

  • 1. Benign Diseases of Thyroid and Hyperthyroidism PRAVEEN R K NO: 75
  • 3. CRETINISM ▶ Inadequate thyroid hormone during foetal and neonatal development ▶ Two types ▶ Endemic - Due to dietary iodine deficiency ▶ Sporadic - Due to either an inborn error of thyroid metabolism or complete or partial agenesis of the gland.
  • 4. CLINICAL FEATURES ▶ Hoarse cry ▶ Macroglossia ▶ Growth retardation ▶ Mental retardation ▶ Umbilical hernia
  • 5. ▶ Immediate diagnosis and treatment with thyroxine within a few days of birth are essential to prevent in utero damage progressing.
  • 6. ADULT HYPOTHYROIDISM ▶ Mild Thyroid deficiency is common ▶ Severe thyroid failure results in Myxoedema
  • 7. SYMPTOMS ▶ Tiredness ▶ Mental lethargy ▶ Cold intolerance ▶ Weight gain ▶ Constipation ▶ Menstrual disturbance ▶ Carpal tunnel syndrome
  • 8. SIGNS ▶ Bradycardia ▶ Cold extremities ▶ Dry skin and hair ▶ Periorbital puffiness ▶ Hoarse voice ▶ Bradykinesia, slow movements ▶ Delayed relaxation phase of ankle jerk
  • 9. LAB FINDINGS ▶ Thyroid function tests ▶ Low T4 and T3 levels with a high TSH ▶ High serum levels of TPO antibodies are characteristic of autoimmune disease.
  • 10. TREATMENT ▶ Oral thyroxine (0.1 – 0.2 mg) as a single daily dose is curative. ▶ Triiodothyronine(20 μg three times a day) , if rapid response is required
  • 11. MYXOEDEMA ▶ Adult onset severe hypothyroidism ▶ The signs and symptoms of hypothyroidism are accentuated ▶ Facial appearance is typical  Supra clavicular puffiness  Malar flush  A yellow tinge to the skin
  • 12. ▶ Myxoedema coma -  Altered mental state  Hypothermia  Precipitating medical condition - cardiac failure or infection  High mortality rate
  • 13. TREATMENT ▶ Thyroid replacement, either as a bolus of 0.5 mg of T4 or 10 μg of T3 either i.v / orally every 4–6 hrs ▶ Body Temp <30oC - warmed slowly ▶ IV broad spectrum antibiotics and Hydrocotisone (divided doses)
  • 14. DYSHORMONOGENESIS Genetic deficiencies in the enzymes controlling the synthesis of thyroid hormones ▶ Inherited as autosomal recessive ▶ Family history is common ▶ If biochemical effect is of moderate degree, Thyroid enlargement may be the only manifestation ▶ Most common abnormalities affect TPO activity and thyroglobulin synthesis. ▶ Eg: Pendred’s syndrome – goitre + severe sensorineural hearing loss + abnormality of bony labyrinth
  • 16. THYROID ENLARGEMENT ▶ Normal thyroid gland is impalpable ▶ ‘Goitre’ – generalised enlargement of thyroid gland
  • 17.
  • 18. SIMPLE GOITRE ▶ Aetiopathogenesis - ▶ Stimulation due to increased TSH  Decreased level of circulating thyroid hormones or due to inappropriate secretion from a microadenoma in ant. Pituitary. ▶ MC factor is dietary deficiency of iodine (endemic goitre) ▶ Following are causes of such goitre: ▶ Endemic goitre -iodine deficiency ▶ Dyshormonogenesis or Enzyme deficiency ▶ Goitrogens – vegetables of brassica (cabbage)
  • 19. Stages of goitre formation ▶ Initially Persistent growth stimulation – diffuse hyperplasia ▶ Later Fluctuating stimulation – mixed pattern with areas of active lobules and inactive lobules ▶ Active lobules – become more vascular & hyperplastic – hemorrhage occurs– central necrosis ▶ Necrotic lobules coalesce – nodules filled with iodine free colloid or mass of new but inactive follicles ▶ Continual repetition of process – results in nodular goitre
  • 20. DIFFUSE HYPERPLASTIC GOITRE ▶ Corresponds to first stage of natural history ▶ Goitre in childhood usually seen in endemic areas, sporadic cases usually occurs in puberty ▶ Goitre is soft, diffuse, large enough to cause discomfort ▶ Colloid goitre occurs in late stage when TSH stimulation has fallen off
  • 21. MULTINODULAR GOITRE ▶ C/P - Females-late 30s or 40s-multiple palpable nodules ▶ Occasionally a solitary nodule may be palpable but there are multiple small nodules impalpable. ▶ Nodules may be colloid or cellular, cystic degeneration and hemorrhage.
  • 22. COMPLICATIONS ▶ Secondary thyrotoxicosis – in about 30% nodular goitre. ▶ Tracheal obstruction – huge goitres or substernal prolongation of goitre ▶ Carcinoma (usually follicular)
  • 23. Investigations ▶ Thyroid Function Tests ▶ Isotope scan-to differentiate hot and cold nodules. ▶ USG ▶ FNAC ▶ Core biopsy ▶ CT and MRI ▶ Thyroid autoantibodies ▶ Chest radiography
  • 24. TREATMENT ▶ Most patients are asymptomatic and do not need operation ▶ Operation may be indicated on cosmetic grounds, for pressure symptoms, or in response to patient anxiety ▶ Choice of surgery ▶ Total thyroidectomy ▶ Subtotal thyroidectomy ▶ Total lobectomy
  • 25. SOLITARY NODULE THYROID ▶ Isolated thyroid swelling ▶ Isolated , confined to one or other lateral lobe or to isthmus. ▶ Mostly they are SNG formed by inactive colloid or apparently localized manifestations of simple MNG. ▶ Also include-#neoplastic - benign/malignant #cysts #localised chronic lymphocytic thyroiditis.
  • 26. THYROID CYSTS ▶ Routine FNAC shows that >30% of clinically isolated swellings contain fluid-are cystic or partially cystic. ▶ Tense cysts – hard &mimic carcinoma ▶ Bleeding into cysts- acute painful swelling. ▶ 50% as a result of colloid degeneration or of uncertain etiology like absence of epithelial cells in the lining. ▶ C/P- In women aged 20-40 yrs - as discrete swellings ▶ Appropriate investigation : FNAC
  • 27. RETROSTERNAL GOITRE ▶ Arise from lower pole of nodular goitre, from ectopic thyroid tissue. ▶ If neck is short and pretracheal muscles are strong , -ve intrathoracic pressure tends to draw the goitre into the superior mediastinum. ▶ Obstructive symptoms - dyspnea, cough and stridor, dysphagia, engorgement of neck veins, recurrent nerve paralysis ▶ Xray- soft tissue shadow in superior mediastinum, deviation and compression of trachea
  • 29. CHRONIC LYMPHOCYTIC THYROIDITIS ▶ Autoimmune disease - HASHIMOTO’S DISEASE ▶ Raised titres of thyroid antibodies. ▶ C/P : diffuse or nodular with a characteristic bosselated feel or subclinical thyroid failure. ▶ Onset may be insidious and asymptomatic or sudden and painful. ▶ Initially mild hyperthyroidism later hypothyroidism ▶ Goitre is usually lobulated ; diffuse or localised to one lobe. ▶ Large or small ; soft , rubbery or firm in consistency- depending on cellularity and degree of fibrosis. ▶ Mc –women at menopause ▶ DIAGNOSIS- Raised serum levels of one or more thyroid antibodies, FNAC, diagnostic lobectomy
  • 30. SUBACUTE THYROIDITIS ▶ Granulomatous thyroiditis ; de Quervain’s thyroiditis. ▶ May follow viral infection ▶ C/F: pain in neck , fever , malaise and firm, irregular enlargement of one or both thyroid lobes ▶ Raised inflammatory markers , absent thyroid antibodies , serum T4 is slightly raised ▶ Self limiting - a period of months of hypothyroidism may be present before eventual recovery ▶ DIAGNOSIS - FNAC , radioactive iodine uptake and by rapid symptomatic response to prednisolone. ▶ TREATMENT- PREDNISOLONE 10-20mg daily for 1 week & then gradually reduced dose over next month
  • 31. REIDEL’S THYROIDITIS ▶ Very rare - 0.5% of goitres. ▶ Thyroid tissue replaced by cellular fibrous tissue - infiltrates through capsule into muscle and adjacent structures including parathyroid, recurrent nerves, carotid sheath. ▶ Probably a collagen disease ▶ Goitre may be U/L or B/L - very hard and fixed ▶ TREATMENT-High dose steroid, tamoxifen, thyroxine replacement
  • 33. HYPERTHYROIDISM ▶ Hyperthyroidism –term used for over production of thyroid hormones ▶ Pathology is in thyroid gland itself ▶ Hyperthyroidism is one of the causes of thyrotoxicosis ▶ Thyrotoxicosis is symptom complex due to increased levels of thyroid hormones ▶ It refers to biochemical and physiological manifestations of excessive thyroid hormones
  • 34. CLINICAL CLASSIFICATION ▶ Diffuse toxic goitre (Graves’ disease, Primary thyrotoxicosis) ▶ Toxic nodular goitre (Secondary thyrotoxicosis) ▶ Toxic nodule ▶ Hyperthyroidism due to rarer causes
  • 35. Diffuse toxic goitre (Grave’s Disease) ▶ A Diffuse vascular goitre appearing at the same time as the hyperthyroidism, usually occurs in younger women and is frequently associated with eye signs. ▶ The syndrome is that of primary thyrotoxicosis ▶ 50 % family history of autoimmune endocrine diseases. ▶ Thyroid stimulating immunoglobulins and long acting thyroid stimulator are responsible for pathological changes. ▶ Whole functioning thyroid tissue is involved ▶ Hypertrophy and hyperplasia due to abnormal thyroid stimulating antibodies (TSH-RAb) that bind to TSH receptor sites and produce a disproportionate and prolonged effect
  • 36. TOXIC NODULAR GOITRE ▶ Simple nodular goitre is present for a long time before the hyperthyroidism, usually in the middle-aged or elderly, and very infrequently associated with eye signs ▶ The syndrome is that of secondary thyrotoxicosis. ▶ In many cases- nodules are inactive ▶ Inter nodular thyroid tissue – over active ▶ However, in some toxic nodular goitres, one or more nodules are overactive and here the hyperthyroidism is due to autonomous thyroid tissue as in a toxic adenoma
  • 37. TOXIC NODULE ▶ A solitary overactive nodule ▶ It may be part of a generalised nodularity or a true toxic adenoma. ▶ It is autonomous and its hypertrophy and hyperplasia are not due to TSH-R Ab. ▶ TSH secretion is suppressed by the high level of circulating thyroid hormones and the normal thyroid tissue surrounding the nodule is itself suppressed and inactive.
  • 38. Symptomatology ▶ 8 times more common in women ▶ Significant symptoms- loss of weight despite good appetite, recent preference for cold, and palpitations ▶ Significant signs- excitability of patient, presence of goitre, exophthalmos, tachycardia or cardiac arrhythmia ▶ Primary thyrotoxicosis- goitre is diffuse and vascular, large or small, firm or soft, onset is abrupt, a thrill and a bruit may be present, ▶ Secondary thyrotoxicosis- goitre is nodular, onset is insidious, may present with cardiac failure or atrial fibrillation
  • 39. CLINICAL FEATURE Symptoms ▶ Tiredness ▶ Emotional liability ▶ Heat intolerance ▶ Weight loss ▶ Excessive appetite ▶ Palpitations ▶ Proximal myopathy
  • 40. EYE SIGNS LID RETRACTION ▶ Over activity of involuntary part of the levator palpebrae superioris muscle. ▶ The upper eye lid is higher than normal and the lower eyelid is in its normal position Exophthalmos ▶ When eyeball is pushed forwards due to increase in fat or oedema or cellular infiltration in the retro orbital space the eyelids are retracted and sclera becomes visible below the lower edge of the iris first followed by above the upper edge of the iris
  • 41.
  • 42. ▶ Von Graefe's sign.— The upper eyelid lags behind the eyeball as the patient is asked to look downwards. ▶ Stellwag's sign — This is staring look and infrequent blinking of eyes with widening of palpebral fissure ▶ Joffroy’s sign – absence of wrinkling on forehead when patient looks up with head bent down. ▶ Moebius' sign — Inability or failure to converge the eyeballs. ▶ Dalrymple's sign— The upper sclera is visible due to retraction of upper eye lid ▶ Ophthalmoplegia ▶ Chemosis, papilloedema, corneal ulcer
  • 43. ▶ Cardiac manifestations ▶ Multiple extrasystoles, paroxysmal atrial tachycardia, paroxysmal atrial fibrillation, persistent atrial fibrillation ▶ Myopathy ▶ Proximal muscle weakness ▶ Pretibial myxoedema ▶ Bilateral, symmetrical, shiny red, thickened dry skin with coarse hair in feet and ankles ▶ Usually in areas of trauma , by deposition of hyaluronic acid in dermis and subcutis
  • 44. INVESTIGATIONS ▶ Thyroid function tests Type of disease T 4 T3 TSH Hyperthyroidism Increased Increased Undetectable
  • 45. ▶ Radioisotope study – I123 more uptake – hot nodules ▶ TRH estimation ▶ ECG- cardiac involvement ▶ Total count and neutrophil count ▶ Thyroid antibody estimation
  • 46. TREATMENT ▶ Relief of symptoms ▶ Beta blocker- control cardiovascular manifestation ▶ Calcium channel blocker ▶ Oral rehydration ▶ Antithyroid drugs ▶ Methimazole 20 – 40 mg OD (blocks thyroid hormone synthesis) ▶ Carbimazole 5-10 mg three times a day ▶ Propyl thiouracil 200 mg three times a day (blocks thyroid hormone synthesis as well as blocks peripheral conversion of T4 to T3) ▶ Iodides – reduce vascularity ▶ Steroids
  • 47. ▶ Radioactive iodine therapy – I131 ▶ Destroys cells and cause complete ablation of thyroid gland ▶ Usual dose- 5 to 10 millicurie or 160 microcurie/gm of thyroid ▶ Surgery ▶ Total thyroidectomy ▶ Subtotal thyroidectomy ▶ Hemithyroidectomy